Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

INBX

Inhibrx Biosciences, Inc.

Last Close
May 31 04:00PM ET
16.25
Dollar change
+0.39
Percentage change
2.46
%
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week-
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter-
Sales- P/S- EPS this Y- Inst Trans- Short Ratio- Perf Half Y-
Book/sh- P/B- EPS next Y- ROA- Short Interest- Perf Year-
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range12.95 - 15.99 Perf YTD16.74%
Dividend Est.- P/FCF- EPS past 5Y- ROI- 52W High1.63% Beta-
Dividend TTM- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low25.48% ATR (14)1.46
Dividend Ex-Date- Current Ratio- EPS Y/Y TTM- Oper. Margin- RSI (14)- Volatility- -
Employees- Debt/Eq- Sales Y/Y TTM- Profit Margin- Recom- Target Price-
Option/ShortNo / No LT Debt/Eq- EPS Q/Q- Payout- Rel Volume1.10 Prev Close15.86
Sales Surprise- EPS Surprise- Sales Q/Q- Earnings- Avg Volume493.14K Price16.25
SMA209.13% SMA509.13% SMA2009.13% Trades Volume543,877 Change2.46%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Eckelman Brendan P.Chief Scientific OfficerMay 28 '24Sale34.30300,00010,290,0001,735,553May 30 06:21 PM
VIKING GLOBAL INVESTORS LP10% OwnerAug 28 '23Buy19.35511,6279,899,982511,627Aug 30 08:44 PM